These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 14732626

  • 21. [Evaluation of a simplified maintenance of wakefulness test for the diagnosis of daytime sleepiness].
    Luo YM, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):847-9. PubMed ID: 15730787
    [Abstract] [Full Text] [Related]

  • 22. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
    Romigi A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P.
    J Neurol Sci; 2005 Jan 15; 228(1):7-10. PubMed ID: 15607203
    [Abstract] [Full Text] [Related]

  • 23. Dopamine agonists and sleepiness in PD: review of the literature and personal findings.
    Manni R, Terzaghi M, Sartori I, Mancini F, Pacchetti C.
    Sleep Med; 2004 Mar 15; 5(2):189-93. PubMed ID: 15033142
    [Abstract] [Full Text] [Related]

  • 24. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, Parkinson Study Group.
    Arch Neurol; 2004 Jul 15; 61(7):1044-53. PubMed ID: 15262734
    [Abstract] [Full Text] [Related]

  • 25. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 26. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U, Siccoli MM, Poryazova R, Werth E, Bassetti CL.
    Eur Neurol; 2009 May 15; 62(3):176-9. PubMed ID: 19602890
    [Abstract] [Full Text] [Related]

  • 27. Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
    Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH, In Cooperation With the German Competence Network on Parkinson’s Disease.
    Clin Neuropharmacol; 2014 May 15; 37(4):116-22. PubMed ID: 24992083
    [Abstract] [Full Text] [Related]

  • 28. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
    Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R.
    Clin Neuropharmacol; 2010 May 15; 33(1):5-10. PubMed ID: 19855267
    [Abstract] [Full Text] [Related]

  • 29. Excessive daytime sleepiness in adults with brain injuries.
    Masel BE, Scheibel RS, Kimbark T, Kuna ST.
    Arch Phys Med Rehabil; 2001 Nov 15; 82(11):1526-32. PubMed ID: 11689971
    [Abstract] [Full Text] [Related]

  • 30. Excessive daytime sleepiness in de novo and treated Parkinson's disease.
    Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G.
    Mov Disord; 2002 Sep 15; 17(5):1026-30. PubMed ID: 12360553
    [Abstract] [Full Text] [Related]

  • 31. Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease.
    Linazasoro G, Spanish Dopamine Agonists Study Group.
    Clin Neuropharmacol; 2008 Sep 15; 31(1):19-24. PubMed ID: 18303487
    [Abstract] [Full Text] [Related]

  • 32. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY, Chung EJ, Park SW, Lee WY.
    Mov Disord; 2006 Aug 15; 21(8):1261-4. PubMed ID: 16685692
    [Abstract] [Full Text] [Related]

  • 33. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
    Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O.
    Eur J Neurol; 2005 Mar 15; 12(3):199-207. PubMed ID: 15693809
    [Abstract] [Full Text] [Related]

  • 34. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.
    Monaca C, Duhamel A, Jacquesson JM, Ozsancak C, Destée A, Guieu JD, Defebvre L, Derambure P.
    Sleep Med; 2006 Aug 15; 7(5):448-53. PubMed ID: 16740409
    [Abstract] [Full Text] [Related]

  • 35. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG.
    Mov Disord; 2003 Feb 15; 18(2):176-80. PubMed ID: 12539211
    [Abstract] [Full Text] [Related]

  • 36. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
    Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR.
    J Neural Transm (Vienna); 2001 Feb 15; 108(1):71-7. PubMed ID: 11261748
    [Abstract] [Full Text] [Related]

  • 37. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ.
    Mov Disord; 2008 Jan 15; 23(1):35-41. PubMed ID: 17960797
    [Abstract] [Full Text] [Related]

  • 38. [Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment].
    Wichniak A, Waliniowska E, Wierzbicka A, Czasak K, Musińska I, Szatkowska E, Jernajczyk W, Jarema M.
    Psychiatr Pol; 2009 Jan 15; 43(2):193-202. PubMed ID: 19697789
    [Abstract] [Full Text] [Related]

  • 39. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R, Benninger D, Waldvogel D, Bassetti CL.
    Eur Neurol; 2010 Jan 15; 63(3):129-35. PubMed ID: 20090346
    [Abstract] [Full Text] [Related]

  • 40. Predictors of sudden onset of sleep in Parkinson's disease.
    Körner Y, Meindorfner C, Möller JC, Stiasny-Kolster K, Haja D, Cassel W, Oertel WH, Krüger HP.
    Mov Disord; 2004 Nov 15; 19(11):1298-305. PubMed ID: 15389999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.